论文部分内容阅读
在肾功能不全患者高血压发生机理方面，肾素—血管紧张素—醛固酮系统（RAAS）是一个重要的因子，不少报告认为肾实质性高血压伴肾功能不全的患者血浆RAAS活性显著增高[1，2]。据此，我们对肾实质性高血压伴肾功能不全患者采用血管紧张素1转换酶抑制剂（ACEI）开博通治疗．取得
Renal-angiotensin-aldosterone system (RAAS) is an important factor in the pathogenesis of hypertension in patients with renal insufficiency. Many reports suggest that plasma RAAS activity is significantly increased in patients with renal parenchymal hypertension and renal insufficiency [ 1,2]. Accordingly, we use angiotensin-1 converting enzyme inhibitor (ACEI) Kai Bo Tong treatment of renal parenchymal hypertension with renal insufficiency. Get